What Is NAD+ and How It Helps Senior Dogs: An Evidence-First Guide

By Jessica Ennis, DVM, CVA

Senior & longevity · July 1, 2026

NAD+ is a cellular coenzyme that fuels energy metabolism, and supporting it may help senior dogs stay active.

If you have started reading about senior-dog longevity, you have probably run into three letters over and over: NAD+. It shows up on supplement labels and in headlines about “reversing aging,” usually with more enthusiasm than explanation. This guide is the plain-language, evidence-first version. I will walk through what NAD+ actually is, why it fades as dogs get older, what the research in dogs versus other species really shows, and how to think about all of it without getting swept up in marketing.

What NAD+ actually is

NAD+ stands for nicotinamide adenine dinucleotide. It is a coenzyme, a small helper molecule that hundreds of enzymes need in order to do their jobs. Your dog’s body makes NAD+ from forms of vitamin B3, including nicotinic acid, nicotinamide, and nicotinamide riboside. According to the NIH Office of Dietary Supplements, more than 400 enzymes require NAD to catalyze reactions in the body, which is more than for any other vitamin-derived coenzyme.

Its most fundamental role is in energy metabolism. NAD+ is a coenzyme for the redox reactions that turn food into usable cellular energy, participating in glycolysis, the citric acid (TCA) cycle, and oxidative phosphorylation in the mitochondria. Beyond producing energy, NAD+ is also a required cofactor for a family of enzymes involved in DNA repair, the stress-response, and how cells regulate their own maintenance, including sirtuins, PARPs, and CD38. In plain terms: NAD+ is one of the molecules that keeps the cellular machinery running and repairing itself day to day.

Why NAD+ declines with age

Here is where aging comes in. Research summarized in Nature Reviews Molecular Cell Biology describes how aging is accompanied by a gradual decline in tissue and cellular NAD+ levels across multiple species, including rodents and humans. The picture is not perfectly settled, and some researchers argue the size and universality of that decline is still being worked out, but the general trend of lower NAD+ availability in older tissues is well documented.

The intuitive story is that as NAD+ becomes less available, the enzymes that depend on it, the ones handling energy production and cellular upkeep, have less of what they need. That is a structure-and-function way of thinking about it: NAD+ helps support the normal cellular processes behind everyday energy metabolism, and those processes tend to run less smoothly with age. It is worth being honest that this is a plausible mechanism, not a proven fix for any specific disease.

Why this matters for senior dogs

Dogs age too, and the cognitive side of aging is real and common. In the Dog Aging Project, researchers found that the odds of canine cognitive dysfunction (the dog analog of age-related cognitive decline) increased about 52% with each additional year of age, even after accounting for other health factors. Many owners quietly write off early changes, slower response to their name, disrupted sleep, new anxiety, as “just getting old,” which is exactly why these changes are underdiagnosed.

That is the backdrop that makes NAD+ interesting for senior dogs. If lower NAD+ is part of the cellular story of aging, then supporting the body’s ability to make NAD+ is a reasonable thing to study. Whether it delivers a meaningful, visible benefit in your individual dog is a separate question, and one the evidence is only beginning to answer.

What the evidence actually shows: dogs vs. other species

This is the section most articles skip, so let me be specific.

In humans, a well-conducted randomized crossover trial published in Nature Communications found that chronic supplementation with the NAD+ precursor nicotinamide riboside (NR) was well tolerated and effectively elevated NAD+ metabolism in healthy middle-aged and older adults. That establishes the basic biology: you can raise NAD+ markers by feeding the body the right precursor.

In dogs, the most relevant study is a 2024 randomized, controlled clinical trial in Scientific Reports. Seventy senior dogs with mild-to-moderate cognitive impairment were assigned to placebo, low-dose, or full-dose groups of a combination product pairing a senolytic with an NAD+ precursor. Over three months, there was a significant difference in owner-reported cognitive scores across groups (p = 0.02), with the full-dose group showing the largest improvement. That is genuinely encouraging.

But good writing names the trade-offs. The same study found the effect did not persist at the six-month mark, when scores plateaued across all groups. Independent evidence-based veterinarians, such as the SkeptVet, have pointed out that the outcome was owner-reported (subjective), that every group including placebo tended to improve, and that this is early rather than definitive evidence. It is also a combination product, so we cannot cleanly attribute the effect to the NAD+ precursor alone. Honest summary: promising signal, small trial, subjective endpoint, benefit that faded, more research needed.

How owners should think about NAD+

A few practical guardrails keep expectations realistic.

First, you cannot meaningfully supplement NAD+ directly. It is poorly absorbed and does not cross cell membranes well, which is why supplements use precursors the body converts into NAD+. Of those, nicotinamide riboside (NR) currently has the most consistent mammalian safety and bioavailability data.

Second, NAD+ support is a “may help support” tool, not a cure. It is reasonable to think of a well-formulated NAD+ precursor as one part of a daily routine aimed at supporting normal cellular energy metabolism and overall vitality in an aging dog, alongside the boring fundamentals that have far stronger evidence: appropriate body weight, regular exercise and mental enrichment, a complete diet, dental care, and staying current on veterinary checkups.

These statements have not been evaluated by the FDA. Supplements of this kind are not intended to diagnose, treat, cure, or prevent any disease.

When to talk to your vet

Supplements are not a substitute for a diagnosis. If your senior dog is showing new or worsening signs, disorientation, pacing at night, getting “stuck” in corners, forgetting house-training, or notable changes in interaction, book a real exam. Several treatable medical problems (pain, vision or hearing loss, endocrine disease) can look like cognitive decline, and you want those ruled in or out.

Bring up any longevity supplement with your veterinarian before starting it, particularly if your dog takes medication, has a chronic condition, or is very old or frail. Ask about the specific ingredient and dose, look for products from companies that participate in independent quality programs such as the National Animal Supplement Council (NASC) and do third-party testing, and set a realistic time frame to reassess. NAD+ science is moving quickly and is worth following, but for your individual senior dog, the most valuable thing you can do is pair curiosity about the research with a good relationship with your vet.